Skip to content

Insulet PODD Change in net unrealized gain (loss) on derivative instruments

Change in net unrealized gain (loss) on derivative instruments at other companies

Ovintiv logo
OvintivOVV
-$53M-15.2%
Wintrust Financial logo
Wintrust FinancialWTFC
$17.45M
Annaly Capital Management logo
Annaly Capital ManagementNLY
$409.11M+142%
Two Harbors Investment Corporation logo
Two Harbors Investment CorporationTWO
$26.94M+125%
EFC
Ellington Financial Inc.EFC
Blackstone Mortgage Trust logo
Blackstone Mortgage TrustBXMT

Other financials

Income statement

See full
Revenue$761.7M+33.9%
Gross profit$529.0M+29.3%
Operating income$122.1M+37.5%
Net income$91.1M+157%
EPS (diluted)$1.30+160%

Balance sheet

See full
Cash & equivalents$480.4M-62.6%
Total debt$969.7M-45.5%
Total equity$1.3B-2.1%
Total assets$3.0B-15.1%

Cash flow

See full
Operating cash flow$113.8M+78.4%
CapEx$24.3M+97.6%
Free cash flow$89.5M+73.8%

Valuation

See full
Market cap$10.1B-19.9%
Enterprise value$10.59B-19.4%
P/E33.3×+2.0×
P/S3.5×-2.3×

Profitability

See full
Gross margin71%+0.6pp
Operating margin17.5%+2.0pp
Net margin10.4%-7.9pp
FCF margin14.3%+1.1pp

Returns & leverage

See full
Return on equity23%-14.9pp
Debt / equity0.7×-0.6×
Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's change in net unrealized gain (loss) on derivative instruments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insulet's change in net unrealized gain (loss) on derivative instruments?
Insulet (PODD) reported change in net unrealized gain (loss) on derivative instruments of -$300K in Q1 2026.
How has Insulet's change in net unrealized gain (loss) on derivative instruments changed year-over-year?
Insulet's change in net unrealized gain (loss) on derivative instruments increased by 90.3% year-over-year, from -$3.1M to -$300K.